We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$1.06B
Cap. Flow
-$389M
Cap. Flow %
-2.8%
Top 10 Hldgs %
25.44%
Holding
2,969
New
81
Increased
186
Reduced
1,131
Closed
145

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$57.5M
2
MDT icon
Medtronic
MDT
+$24.4M
3
UBER icon
Uber
UBER
+$24M
4
AON icon
Aon
AON
+$15.5M
5
TT icon
Trane Technologies
TT
+$12.6M

Sector Composition

Rank Sector Weight
1 Technology 27.1%
2 Financials 12.28%
3 Healthcare 11.96%
4 Consumer Discretionary 11.51%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
2851
Seres Therapeutics
MCRB
$47.4M
-2,572
Closed -$122K
NOTE
2852
DELISTED
FiscalNote
NOTE
-2,901
Closed -$72.4K
ORGN
2853
DELISTED
Origin Materials
ORGN
-1,955
Closed -$75.1K
PMVP icon
2854
PMV Pharmaceuticals
PMVP
$67.2M
-22,144
Closed -$136K
PRPL icon
2855
Purple Innovation
PRPL
$28.4M
-1,293
Closed -$55.3K
RLYB icon
2856
Rallybio
RLYB
$88.1M
-2,122
Closed -$57.2K
RNAC icon
2857
Cartesian Therapeutics
RNAC
$263M
-2,073
Closed -$65.9K
SEDG icon
2858
SolarEdge
SEDG
$1.97B
-12,865
Closed -$1.67M
SEER icon
2859
Seer Inc
SEER
$118M
-31,352
Closed -$69.3K
SGMO
2860
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-67,978
Closed -$40.8K
TELA icon
2861
TELA Bio
TELA
$32.3M
-8,467
Closed -$67.7K
TNYA icon
2862
Tenaya Therapeutics
TNYA
$171M
-25,148
Closed -$64.1K
TUSK icon
2863
Mammoth Energy Services
TUSK
$158M
-12,318
Closed -$57.2K
USIG icon
2864
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
-705,668
Closed -$33.9M
VNQ icon
2865
Vanguard Real Estate ETF
VNQ
$38.6B
-113,900
Closed -$8.62M
VTYX
2866
DELISTED
Ventyx Biosciences
VTYX
-24,841
Closed -$863K
VWO icon
2867
Vanguard FTSE Emerging Markets ETF
VWO
$126B
-92,280
Closed -$3.62M
XFOR icon
2868
X4 Pharmaceuticals
XFOR
$425M
-2,181
Closed -$71.3K
XOMA
2869
DELISTED
Xoma
XOMA
-3,915
Closed -$55.2K
KLRS
2870
Kalaris Therapeutics
KLRS
$93.7M
-927
Closed -$45.8K
CUTR
2871
DELISTED
Cutera, Inc.
CUTR
-8,191
Closed -$49.3K
BCOV
2872
DELISTED
Brightcove, Inc.
BCOV
-21,912
Closed -$72.1K
DNMR
2873
DELISTED
Danimer Scientific, Inc.
DNMR
-1,256
Closed -$104K
LLAP
2874
DELISTED
Terran Orbital Corporation
LLAP
-50,277
Closed -$41.9K
EVA
2875
DELISTED
Enviva Inc.
EVA
-17,049
Closed -$127K

Similar funds

MetLife Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, MetLife Investment Management held 2,969 positions worth $13.9B, up 8.2% from $12.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2023 filing shows 81 new, 186 increased, 1,131 reduced and 145 closed positions. Its largest new stake was Accenture: 178,487 shares worth $62.6M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $81.9M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2023 buy was Accenture: 178,487 shares worth $62.6M.
  • MetLife Investment Management added most to Medtronic in Q4 2023, an estimated $24.4M increase.
  • MetLife Investment Management's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $81.9M.
  • MetLife Investment Management fully exited iShares Core US Aggregate Bond ETF in Q4 2023, selling an estimated $40.8M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.9B portfolio in Q4 2023.
  • MetLife Investment Management opened 81 new positions and closed 145 in Q4 2023.
  • MetLife Investment Management's portfolio value rose 8.2% quarter-over-quarter to $13.9B.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.